Computational modeling of the EGF-receptor system: A paradigm for systems biology

Trends in Cell Biology

Volumn 13, Issue 1, 2003, Pages 43-50

  Wiley, H Steven ^a   Shvartsman, Stanislav Y ^b   Lauffenburger, Douglas A ^c  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b Princeton University   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

CALCULATION; HUMAN; MODEL; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BIOLOGY; CHEMISTRY; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN BINDING;

ANIMALS; COMPUTATIONAL BIOLOGY; HUMANS; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0037213006     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)00009-0     Document Type: Review

References (66)

1. Carpenter G. The EGF receptor: a nexus for trafficking and signaling. BioEssays. 22:2000;697-707.
2. Wells A. EGF receptor. Int. J. Biochem. Cell Biol. 31:1999;637-643.
3. Moghal N., Sternberg P.W. Multiple positive and negative regulators of signaling by the EGF-receptor. Curr. Opin. Cell Biol. 11:1999;190-196.
4. Kitano H. Systems biology: a brief overview. Science. 295:2002;1662-1664.
5. Gex-Fabry M., DeLisi C. Receptor-mediated endocytosis: a model and its implications for experimental analysis. Am. J. Physiol. 247:1984;R768-R779.
6. Wiley H.S., Cunningham D.D. A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands. Cell. 25:1981;433-440.
7. Wiley H.S., Cunningham D.D. The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. J. Biol. Chem. 257:1982;4222-4229.
8. Sugiyama Y., Hanano M. Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body. Pharm. Res. 6:1989;192-202.
9. Lauffenburger D.A., Linderman J.J. Oxford University Press. Oxford University Press. 1993.
10. Wiley H.S., Cunningham D.D. Epidermal growth factor stimulates fluid phase endocytosis in human fibroblasts through a signal generated at the cell surface. J. Cell. Biochem. 19:1982;383-394.
11. Knauer D.J., et al. Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system. J. Biol. Chem. 259:1984;5623-5631.
12. Starbuck C., Lauffenburger D.A. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Biotechnol. Prog. 8:1992;132-143.
13. Waters C.M., et al. Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism. J. Cell. Physiol. 152:1992;253-263.
14. Csete M.E., Doyle J.C. Reverse engineering of biological complexity. Science. 295:2002;1664-1669.
15. Wiley H.S. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system. J. Cell Biol. 107:1988;801-810.
16. Lund K.A., et al. Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J. Biol. Chem. 265:1990;15713-15723.
17. Honegger A.M., et al. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell. 51:1987;199-209.
18. Felder S., et al. Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell. 61:1990;623-634.
19. Wiley H.S., et al. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 266:1991;11083-11094.
20. Chang C.P., et al. Ligand-induced internalization and increased cell calcium are mediated via distinct structural elements in the carboxyl terminus of the epidermal growth factor receptor. J. Biol. Chem. 266:1991;23467-23470.
21. Chang C.P., et al. Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J. Biol. Chem. 268:1993;19312-19320.
22. Opresko L.K., et al. Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain. J. Biol. Chem. 270:1995;4325-4333.
23. Burke P.M., Wiley H.S. Human mammary epithelial cells rapidly exchange empty EGFR between surface and intracellular pools. J. Cell. Physiol. 180:1999;448-460.
24. Wiley H.S., Burke P.M. Regulation of receptor tyrosine kinase signaling by endocytic trafficking. Traffic. 2:2001;12-18.
25. Longva K.E., et al. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156:2002;843-854.
26. French A.R., et al. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem. 270:1995;4334-4340.
27. Waterman H., Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett. 490:2001;142-152.
28. Sorkina T., et al. Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor. J. Biol. Chem. 277:2002;27433-27441.
29. DeWitt A.E., et al. Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture. J. Cell Sci. 114:2001;2301-2313.
30. Wells A., et al. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science. 247:1990;962-964.
31. Reddy C.C., et al. Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect. Biotechnol. Prog. 10:1994;377-384.
32. Fannon M., Nugent M.A. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate. J. Biol. Chem. 271:1996;17949-17956.
33. Reddy C.C., et al. Engineering epidermal growth factor for enhanced mitogenic potency. Nat. Biotechnol. 14:1996;1696-1699.
34. Fallon E.M., et al. Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog. J. Biol. Chem. 275:2000;6790-6797.
35. Sarkar C.A., et al. Rational cytokine design for increased lifetime and enhanced potency using pH-activated 'histidine switching'. Nat. Biotechnol. 20:2002;908-913.
36. Bhalla U.S., Iyengar R. Emergent properties of networks of biological signaling pathways. Science. 283:1999;381-387.
37. Kholodenko B.N., et al. Quantification of short term signaling by the epidermal growth factor receptor. J. Biol. Chem. 274:1999;30169-30181.
38. Ras in fibroblasts. J. Biol. Chem. 274:1999;34350-34360.
39. Schoeberl B., et al. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat. Biotechnol. 20:2002;370-375.
40. Riese D.J. II, Stern D.F. II. Specificity within the EGF family/ErbB receptor family signaling network. BioEssays. 20:1998;41-48.
41. Wofsy C., et al. Implications of epidermal growth factor (EGF) induced EGF receptor aggregation. Biophys. J. 63:1992;98-110.
42. Martin-Fernandez M., et al. Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys. J. 82:2002;2415-2427.
43. Garrett T., et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell. 110:2002;763-773.
44. Worthylake R., et al. ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors. J. Biol. Chem. 274:1999;8865-8874.
45. Waterman H., et al. Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem. 273:1998;13819-13827.
46. Lauffenburger D.A., et al. Real-time quantitative measurement of autocrine ligand binding indicates that autocrine loops are spatially localized. Proc. Natl Acad. Sci. USA. 95:1998;15368-15373.
47. Forsten K.E., Lauffenburger D.A. Autocrine ligand binding to cell receptors. Mathematical analysis of competition by solution 'decoys'. Biophys. J. 61:1992;518-529.
48. Shvartsman S.Y., et al. Spatial range of autocrine signaling: modeling and computational analysis. Biophys. J. 81:2001;1854-1867.
49. Will B.H., et al. Studies on engineered autocrine systems: requirements for ligand release from cells producing an artificial growth factor. Tissue Eng. 1:1995;81-96.
50. DeWitt A.E., et al. Affinity regulates spatial range of EGF receptor autocrine ligand binding. Dev. Biol. 250:2002;305-316.
51. Baselga J., et al. Autocrine regulation of membrane transforming growth factor-alpha cleavage. J. Biol. Chem. 271:1996;3279-3284.
52. Maheshwari G., et al. Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration. J. Cell Biol. 155:2001;1123-1128.
53. Casci T., Freeman M. Control of EGF receptor signalling: lessons from fruitflies. Cancer Metastasis Rev. 18:1999;181-201.
54. Shvartsman S.Y., et al. Modeling and computational analysis of EGF receptor-mediated cell communication in Drosophila oogenesis. Development. 129:2002;2577-2589.
55. Gechtman Z., et al. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J. Biol. Chem. 274:1999;28828-28835.
56. Dong J., Wiley H.S. Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains. J. Biol. Chem. 275:2000;557-564.
57. Dent P., et al. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol. Biol. Cell. 10:1999;2493-2506.
58. Schmidt-Ullrich R.K., et al. Molecular mechanisms of radiation-induced accelerated repopulation. Radiat. Oncol. Investig. 7:1999;321-330.
59. Hagan M., et al. Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell killing and G2/M-phase arrest. Radiat. Res. 153:2000;371-383.
60. Lammering G., et al. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. J. Natl Cancer Inst. 93:2001;921-929.
61. Shvartsman S.Y., et al. Autocrine loops with positive feedback enable context-dependent cell signaling. Am. J. Physiol. Cell. Physiol. 282:2002;C545-C559.
62. Wiley H.S., et al. Intracellular processing of epidermal growth factor and its effect on ligand-receptor interactions. J. Biol. Chem. 260:1985;5290-5295.
63. Haugh J.M., Lauffenburger D.A. Analysis of receptor internalization as a mechanism for modulating signal transduction. J. Theor. Biol. 195:1998;187-218.
64. Burke P., et al. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol. Biol. Cell. 12:2001;1897-1910.
65. Dong J., et al. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc. Natl Acad. Sci. USA. 96:1999;6235-6240.
66. Carpenter G. EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists. Science STKE. (15):2000;PE1.